EyeWorld Korea September 2019 Issue

EWAP SEPTEMBER 2019 15 FEATURE 삽입 직후의 Juvene IOL 전낭 가장자리 밑 miLOOP 배치 출처 (전부): Summit Garg, MD 대처할 수 있게 하였습니다. 안경으로부터의 해방은 환자들이 수술 성공 여부를 판단하는 주된 요인이 되었습니다. 현재 우리가 이용할 수 있는 최신기술은 환자들을 위해 이러한 목표를 이루는 데 도움을 주며, 우리의 일을 수월하게 해주고 안과의로서 직업을 더욱 만족하게 해줍니다." EWAP Editors’ note: Dr. Donaldson is professor of clinical ophthalmology, Bascom Palmer Eye Institute, Plantation, Florida, and has financial interests in Alcon, Allergan, Bausch + Lomb, Bio-Tissue, Johnson & Johnson, Vision, Sun Pharmaceutical, Shire, Kala Pharmaceuticals, Eyevance, Lumenis, and Carl Zeiss Meditec. Dr. Garg is vice chair of clinical ophthalmology, Gavin Herbert Eye Institute, Irvine, California, and has financial interests in Johnson & Johnson Vision, LensGen, and Carl Zeiss Meditec. Dr. Lee practices ophthalmology at Altos Eye Physicians, Los Altos, California, and has related interests in AcuFocus and Carl Zeiss Meditec. Dr. Weinstock practices at the Eye Institute of West Florida, Largo, Florida, and has financial interests in Alcon, LENSAR, and Carl Zeiss Meditec.